
Empallo is developing machine learning algorithms that will eventually result in more personalized treatment strategies for cardiovascular disease patients and better clinical trials.

Empallo is developing machine learning algorithms that will eventually result in more personalized treatment strategies for cardiovascular disease patients and better clinical trials.
Sector: Cardiovascular healthcare / healthtech
Location: Boston, Massachusetts, United States
Stage: Pre-Seed
Employees: 7
Notable investors: Techstars; Right Side Capital Management
Cardiovascular disease management and clinical-trial optimization
Healthcare / Information Technology
150000.00 USD
Crunchbase lists three funding rounds in total; most-recent round recorded as Pre-Seed with Techstars and Right Side Capital Management among investors.
“Techstars; Right Side Capital Management”